| Title |
Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease
|
|---|---|
| Published in |
Diabetologia, April 2019
|
| DOI | 10.1007/s00125-019-4859-4 |
| Pubmed ID | |
| Authors |
Hiddo J. L. Heerspink, Paul Perco, Skander Mulder, Johannes Leierer, Michael K. Hansen, Andreas Heinzel, Gert Mayer |
X Demographics
The data shown below were collected from the profiles of 49 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 7 | 14% |
| Spain | 6 | 12% |
| United States | 4 | 8% |
| India | 4 | 8% |
| Canada | 3 | 6% |
| Chile | 2 | 4% |
| Germany | 1 | 2% |
| Denmark | 1 | 2% |
| Italy | 1 | 2% |
| Other | 3 | 6% |
| Unknown | 17 | 35% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 32 | 65% |
| Scientists | 10 | 20% |
| Practitioners (doctors, other healthcare professionals) | 4 | 8% |
| Science communicators (journalists, bloggers, editors) | 3 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 241 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 241 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 23 | 10% |
| Researcher | 22 | 9% |
| Student > Bachelor | 21 | 9% |
| Student > Master | 20 | 8% |
| Other | 13 | 5% |
| Other | 38 | 16% |
| Unknown | 104 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 73 | 30% |
| Biochemistry, Genetics and Molecular Biology | 16 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 9 | 4% |
| Agricultural and Biological Sciences | 8 | 3% |
| Unspecified | 5 | 2% |
| Other | 16 | 7% |
| Unknown | 114 | 47% |
Attention Score in Context
This research output has an Altmetric Attention Score of 27. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 June 2022.
All research outputs
#1,442,453
of 25,726,194 outputs
Outputs from Diabetologia
#771
of 5,376 outputs
Outputs of similar age
#31,934
of 364,760 outputs
Outputs of similar age from Diabetologia
#16
of 57 outputs
Altmetric has tracked 25,726,194 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,376 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.8. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 364,760 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.